By the first refill, that number had dropped to around 3%
While current commercial products primarily utilize subcutaneous injection, researchers are developing oral tablets with permeation enhancers, mucoadhesive buccal films, intranasal sprays, and even transdermal patch systems
2 Methods 2.1 Trial Design This is a secondary trial report on secondary outcomes from the S-LiTE trial (EudraCT number, 2015-005585-32
We work with pharmacy partners to monitor product availability, shipping timelines, and quality standards
Please work with your healthcare provider to personalize your supplement protocol
doi: 10.31083/j.jin2106167 118